METTL3 can promotes osteogenic differentiation of human aortic valve interstitial cells by inhibiting twist-related protein 1 (TWIST1) expression through an m6A-dependent pathway, aggravating valve calcification and leading to the development of valvular heart disease (Zhou T. et al., 2021). This evidence concerns the gene METTL3 and heart valve disorder.